TRICOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tricor, and when can generic versions of Tricor launch?
Tricor is a drug marketed by Abbvie and is included in three NDAs. There are two patents protecting this drug and two Paragraph IV challenges.
This drug has one hundred and sixty-four patent family members in twenty-seven countries.
The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tricor
A generic version of TRICOR was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
Summary for TRICOR
International Patents: | 164 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 20 |
Patent Applications: | 4,102 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRICOR |
Drug Sales Revenues: | Drug sales revenues for TRICOR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRICOR |
What excipients (inactive ingredients) are in TRICOR? | TRICOR excipients list |
DailyMed Link: | TRICOR at DailyMed |



Recent Clinical Trials for TRICOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of General Medical Sciences (NIGMS) | Phase 2/Phase 3 |
The University of Texas Medical Branch, Galveston | Phase 2/Phase 3 |
Shriners Hospitals for Children | Phase 2/Phase 3 |
Pharmacology for TRICOR
Anatomical Therapeutic Chemical (ATC) Classes for TRICOR
Paragraph IV (Patent) Challenges for TRICOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRICOR | Tablets | fenofibrate | 48 mg | 021656 | 1 | 2008-07-01 |
TRICOR | Tablets | fenofibrate | 145 mg | 021656 | 1 | 2007-10-19 |
US Patents and Regulatory Information for TRICOR
TRICOR is protected by two US patents.
Patents protecting TRICOR
Nanoparticulate fibrate formulations
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods of treatment using nanoparticulate fenofibrate compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-002 | Feb 9, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-003 | Jun 30, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRICOR
See the table below for patents covering TRICOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2059432 | NANOPARTICULES DE MEDICAMENT MODIFIE EN SURFACE (SURFACE MODIFIED DRUG NANOPARTICLES) | ⤷ Try a Trial |
Spain | 2149164 | ⤷ Try a Trial | |
Hungary | 9200226 | ⤷ Try a Trial | |
South Korea | 100200061 | ⤷ Try a Trial | |
Germany | 69811855 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |